• EvoAir posted a net loss of US$1.08 million for the three months ended May 31, 2026, narrowing 9% year over year.
• Revenue more than doubled to US$123,574, while cost of revenue rose to US$116,751, leaving gross profit at US$6,823.
• Operating expenses fell 12% to US$1.09 million, reflecting lower general and administrative costs, including professional fees and compliance costs.
• For the nine months ended May 31, net loss narrowed 56% to US$3.12 million as revenue rose 32% to US$211,613.
• Management cited distribution expansion, project collaborations, private labeling and licensing, while pursuing additional funding and preparations to uplist to Nasdaq.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evoair Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-032788), on July 10, 2026, and is solely responsible for the information contained therein.